Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 7/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.33 |
| ▸ | PTPRF | P10586 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PTPRA | P18433 | 1/20 | 0.33 |
| ▸ | PTPRB | P23467 | 1/20 | 0.33 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.33 |
| ▸ | CDC14B | O60729 | 1/20 | 0.32 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21031788 | 0.91 | AHR (0.36) | AHRPTPRCPTPRFPTPN1PTPRA | |
| SCHEMBL22694906 | 0.91 | AHR (0.39) | AHRCDC14BCDC14AALOX5PDK2 | |
| SCHEMBL21031786 | 0.88 | AHR (0.34) | AHRCDC14BCDC14AALOX5PDK2 | |
| SCHEMBL22694775 | 0.87 | PTPRC (0.35) | PTPRCPTPRFPTPN1PTPRAPTPRB | |
| SCHEMBL21349942 | 0.84 | AHR (0.36) | AHRPTPRCPTPRFPTPN1PTPRA | |
| SCHEMBL18927133 | 0.82 | CDC14B (0.38) | AHRPTPRCPTPRFPTPN1PTPRA | |
| SCHEMBL22694903 | 0.81 | AHR (0.35) | AHRALOX5 | |
| SCHEMBL20927644 | 0.80 | AHR (0.38) | AHRPTPRCPTPRFPTPN1PTPRA | |
| SCHEMBL20927696 | 0.79 | AHR (0.35) | AHRPTPRCPTPRFPTPN1PTPRA | |
| SCHEMBL21031045 | 0.79 | AHR (0.33) | AHRALOX5PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200369678-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369678-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, EFNA1, EPCAM | AHR 3734/4885PTPRC 3705/4885PTPRF 3727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.